Human Mesenchymal Stem Cells Protect Human Islets from Pro-Inflammatory Cytokines

Transplantation of human islets is an attractive alternative to daily insulin injections for patients with type 1 diabetes. However, the majority of islet recipients lose graft function within five years. Inflammation is a primary contributor to graft loss, and inhibiting pro-inflammatory cytokine a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Telford Y., Seeberger, Karen L., Kin, Tatsuya, Adesida, Adetola, Jomha, Nadr, Shapiro, A. M. James, Korbutt, Gregory S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364233/
https://www.ncbi.nlm.nih.gov/pubmed/22666480
http://dx.doi.org/10.1371/journal.pone.0038189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364233/
https://www.ncbi.nlm.nih.gov/pubmed/22666480
http://dx.doi.org/10.1371/journal.pone.0038189

Ejemplares similares